L-Fucose

L-岩藻糖

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameL-Fucose
Drug Alias NameL-fucoseL岩藻糖alpha-L-fucoseSLC35C1-CDGCERC-803 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycosylation inhibitorsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsGlucose transporter type 1 deficiency syndromeMetabolic DiseasesLeukocyte-Adhesion Deficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesIchorion Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityAUG Therapeutics LLCAvalo Therapeutics Inc +[4] 
Inactive CompaniesN/A
Active IndicationsGlucose transporter type 1 deficiency syndromeMetabolic DiseasesLeukocyte-Adhesion Deficiency Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A